TransCode Therapeutics (RNAZ)
(Delayed Data from NSDQ)
$0.26 USD
+0.01 (2.41%)
Updated Sep 13, 2024 03:59 PM ET
After-Market: $0.26 0.00 (0.35%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.49 |
EPS Last Quarter | -0.74 |
Last EPS Surprise | -27.59% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.06 |
Next Year | -0.60 |
EPS (TTM) | -774.80 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.30M | 0.30M | 0.50M | 1.00M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.30M | 0.30M | 0.50M | 1.00M |
Low Estimate | 0.30M | 0.30M | 0.50M | 1.00M |
Year ago Sales | 0.00M | NA | NA | 0.50M |
Year over Year Growth Est. | NA | NA | NA | 100.00% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.49 | -0.19 | -2.06 | -0.60 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.49 | -0.19 | -2.06 | -0.60 |
High Estimate | -0.49 | -0.19 | -2.06 | -0.60 |
Low Estimate | -0.49 | -0.19 | -2.06 | -0.60 |
Year ago EPS | -67.20 | NA | -103.61 | -2.06 |
Year over Year Growth Est. | 99.27% | NA | 98.01% | 70.87% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 0 | 1 |
Up Last 60 Days | 0 | 1 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 0 |
Down Last 60 Days | 1 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.49 | -0.19 | -2.06 | -0.60 |
7 Days Ago | -0.49 | -0.19 | -2.06 | -0.60 |
30 Days Ago | -0.35 | -0.39 | -1.98 | -0.67 |
60 Days Ago | -0.35 | -0.39 | -1.98 | -0.67 |
90 Days Ago | -0.35 | -0.39 | -1.98 | -0.67 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.49 | -0.19 | -2.06 | -0.60 |
Zacks Consensus Estimate | -0.49 | -0.19 | -2.06 | -0.60 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.74 | -0.65 | NA | -67.20 | NA |
Estimate | -0.58 | -0.70 | NA | -60.00 | NA |
Difference | -0.16 | 0.05 | NA | -7.20 | -2.44 |
Surprise | -27.59% | 7.14% | NA | -12.00% | -10.82% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more